Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Vaxart, Inc. | bota20160630_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - Vaxart, Inc. | ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Vaxart, Inc. | ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Vaxart, Inc. | ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Vaxart, Inc. | ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - Vaxart, Inc. | ex23-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Vaxart, Inc. | ex21-1.htm |
| EX-3.2 - EXHIBIT 3.2 - Vaxart, Inc. | ex3-2.htm |
| EX-3.1 - EXHIBIT 3.1 - Vaxart, Inc. | ex3-1.htm |
Exhibit 23.1a
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-205272) and Form S-8 (No. 333-188111, No. 333-134954, No. 333-143238 and No. 333-143239) of Aviragen Therapeutics, Inc. (formerly known as Biota Pharmaceuticals, Inc.) of our report dated September 11, 2015 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Atlanta, GA
September 13, 2016